Literature DB >> 25736437

Catching the adaptor-WDFY1, a new player in the TLR-TRIF pathway.

Ramya Nandakumar1, Søren R Paludan1.   

Abstract

The innate immune system detects microbes and abnormal self through pattern recognition receptors (PRRs), which detect molecules that are either specific for microbes (such as lipopolysaccharide), present in much higher concentrations during infection (such as double-stranded RNA), or present in aberrant locations (such as cytosolic DNA) [1]. The Toll-like receptors (TLRs) are the best-described set of PRRs. TLRs are membrane-bound receptors localized on the plasma membrane and in endosomes, the ligand-binding regions of which face the extracellular environment and the endosomal lumen, respectively [1]. In this issue of EMBO Reports, Hu and colleagues report that WD-repeat and FYVE-domain-containing protein 1 (WDFY1) recruits the signaling adaptor TRIF to TLR3 and TLR4, thereby potentiating signaling from these PRRs (Fig 1); [2].

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25736437      PMCID: PMC4388604          DOI: 10.15252/embr.201540145

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  10 in total

1.  MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways.

Authors:  R Medzhitov; P Preston-Hurlburt; E Kopp; A Stadlen; C Chen; S Ghosh; C A Janeway
Journal:  Mol Cell       Date:  1998-08       Impact factor: 17.970

Review 2.  Toll-like receptors and their crosstalk with other innate receptors in infection and immunity.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Immunity       Date:  2011-05-27       Impact factor: 31.745

3.  Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling.

Authors:  Masahiro Yamamoto; Shintaro Sato; Kiyotoshi Mori; Katsuaki Hoshino; Osamu Takeuchi; Kiyoshi Takeda; Shizuo Akira
Journal:  J Immunol       Date:  2002-12-15       Impact factor: 5.422

4.  Herpes simplex encephalitis in children with autosomal recessive and dominant TRIF deficiency.

Authors:  Vanessa Sancho-Shimizu; Rebeca Pérez de Diego; Lazaro Lorenzo; Rabih Halwani; Abdullah Alangari; Elisabeth Israelsson; Sylvie Fabrega; Annabelle Cardon; Jerome Maluenda; Megumi Tatematsu; Farhad Mahvelati; Melina Herman; Michael Ciancanelli; Yiqi Guo; Zobaida AlSum; Nouf Alkhamis; Abdulkarim S Al-Makadma; Ata Ghadiri; Soraya Boucherit; Sabine Plancoulaine; Capucine Picard; Flore Rozenberg; Marc Tardieu; Pierre Lebon; Emmanuelle Jouanguy; Nima Rezaei; Tsukasa Seya; Misako Matsumoto; Damien Chaussabel; Anne Puel; Shen-Ying Zhang; Laurent Abel; Saleh Al-Muhsen; Jean-Laurent Casanova
Journal:  J Clin Invest       Date:  2011-11-21       Impact factor: 14.808

5.  TIRAP: an adapter molecule in the Toll signaling pathway.

Authors:  T Horng; G M Barton; R Medzhitov
Journal:  Nat Immunol       Date:  2001-09       Impact factor: 25.606

6.  WDFY1 mediates TLR3/4 signaling by recruiting TRIF.

Authors:  Yun-Hong Hu; Yu Zhang; Li-Qun Jiang; Shuai Wang; Cao-Qi Lei; Ming-Shun Sun; Hong-Bing Shu; Yu Liu
Journal:  EMBO Rep       Date:  2015-03-03       Impact factor: 8.807

7.  Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction.

Authors:  K A Fitzgerald; E M Palsson-McDermott; A G Bowie; C A Jefferies; A S Mansell; G Brady; E Brint; A Dunne; P Gray; M T Harte; D McMurray; D E Smith; J E Sims; T A Bird; L A O'Neill
Journal:  Nature       Date:  2001-09-06       Impact factor: 49.962

8.  TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction.

Authors:  Hiroyuki Oshiumi; Misako Matsumoto; Kenji Funami; Takashi Akazawa; Tsukasa Seya
Journal:  Nat Immunol       Date:  2003-01-21       Impact factor: 25.606

9.  TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway.

Authors:  Masahiro Yamamoto; Shintaro Sato; Hiroaki Hemmi; Satoshi Uematsu; Katsuaki Hoshino; Tsuneyasu Kaisho; Osamu Takeuchi; Kiyoshi Takeda; Shizuo Akira
Journal:  Nat Immunol       Date:  2003-10-12       Impact factor: 25.606

10.  LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF.

Authors:  Katherine A Fitzgerald; Daniel C Rowe; Betsy J Barnes; Daniel R Caffrey; Alberto Visintin; Eicke Latz; Brian Monks; Paula M Pitha; Douglas T Golenbock
Journal:  J Exp Med       Date:  2003-09-29       Impact factor: 14.307

  10 in total
  4 in total

1.  Hes1 attenuates type I IFN responses via VEGF-C and WDFY1.

Authors:  Fei Ning; Xiaoyu Li; Li Yu; Bin Zhang; Yuna Zhao; Yu Liu; Baohong Zhao; Yingli Shang; Xiaoyu Hu
Journal:  J Exp Med       Date:  2019-04-23       Impact factor: 14.307

2.  β2 Integrins on Dendritic Cells Modulate Cytokine Signaling and Inflammation-Associated Gene Expression, and Are Required for Induction of Autoimmune Encephalomyelitis.

Authors:  Monika Bednarczyk; Vanessa Bolduan; Maximilian Haist; Henner Stege; Christoph Hieber; Lisa Johann; Carsten Schelmbauer; Michaela Blanfeld; Khalad Karram; Jenny Schunke; Tanja Klaus; Ingrid Tubbe; Evelyn Montermann; Nadine Röhrig; Maike Hartmann; Jana Schlosser; Tobias Bopp; Björn E Clausen; Ari Waisman; Matthias Bros; Stephan Grabbe
Journal:  Cells       Date:  2022-07-13       Impact factor: 7.666

3.  NRP2 transcriptionally regulates its downstream effector WDFY1.

Authors:  Samikshan Dutta; Sohini Roy; Navatha S Polavaram; Gustavo B Baretton; Michael H Muders; Surinder Batra; Kaustubh Datta
Journal:  Sci Rep       Date:  2016-03-30       Impact factor: 4.379

4.  Forsythoside B attenuates memory impairment and neuroinflammation via inhibition on NF-κB signaling in Alzheimer's disease.

Authors:  Fan'ge Kong; Xue Jiang; Ruochen Wang; Siyu Zhai; Yizhi Zhang; Di Wang
Journal:  J Neuroinflammation       Date:  2020-10-15       Impact factor: 8.322

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.